Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam R Winstock

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Drug and Alcohol Review|November 26, 2009
Why do patients report transferring between methadone and buprenorphine?Adam R Winstock, Nicholas Lintzeris, Toby Lea
Drug and Alcohol Review|June 28, 2008
Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatmentAdam R Winstock, Toby Lea, Janie Sheridan
Drug and Alcohol Review|June 15, 2007
The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in AustraliaAdam R Winstock, Toby Lea, Alison Ritter
Translational Psychiatry|September 6, 2022
Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabisTabea Schoeler, Jason Ferris, Adam R Winstock
Journal of Addictive Diseases|February 16, 2010
What is diversion of supervised buprenorphine and how common is it?Adam R Winstock, Toby Lea, Janie Sheridan
Addiction (Abingdon, England)|January 19, 2010
Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, AustraliaAdam R Winstock, Toby Lea, Janie Sheridan
BMJ (Clinical Research Ed.)|August 5, 2017
A new drug strategy for the UKAdam R Winstock, Niamh Eastwood, Alex Stevens
BJU International|October 24, 2014
Where next in ketamine uropathy? Dedicated management centres?Claire F Taylor, Adam R Winstock, Jonathon Olsburgh
Journal of Addictive Diseases|February 7, 2009
Methods and motivations for buprenorphine diversion from public opioid substitution treatment clinicsAdam R Winstock, Toby Lea, Anthony P Jackson
The Medical Journal of Australia|June 14, 2006
National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in AustraliaAdam R Winstock, Caroline M Anderson, Janie Sheridan
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Drug and Alcohol Review|November 26, 2009
Why do patients report transferring between methadone and buprenorphine?Adam R Winstock, Nicholas Lintzeris, Toby Lea
Drug and Alcohol Review|June 28, 2008
Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatmentAdam R Winstock, Toby Lea, Janie Sheridan
Drug and Alcohol Review|June 15, 2007
The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in AustraliaAdam R Winstock, Toby Lea, Alison Ritter
Translational Psychiatry|September 6, 2022
Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabisTabea Schoeler, Jason Ferris, Adam R Winstock
Journal of Addictive Diseases|February 16, 2010
What is diversion of supervised buprenorphine and how common is it?Adam R Winstock, Toby Lea, Janie Sheridan
Addiction (Abingdon, England)|January 19, 2010
Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, AustraliaAdam R Winstock, Toby Lea, Janie Sheridan
BMJ (Clinical Research Ed.)|August 5, 2017
A new drug strategy for the UKAdam R Winstock, Niamh Eastwood, Alex Stevens
BJU International|October 24, 2014
Where next in ketamine uropathy? Dedicated management centres?Claire F Taylor, Adam R Winstock, Jonathon Olsburgh
Journal of Addictive Diseases|February 7, 2009
Methods and motivations for buprenorphine diversion from public opioid substitution treatment clinicsAdam R Winstock, Toby Lea, Anthony P Jackson
The Medical Journal of Australia|June 14, 2006
National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in AustraliaAdam R Winstock, Caroline M Anderson, Janie Sheridan
Pageof 9